Daily Pointer Logo
30 September,2022
Domestic Indices
29-Sep-22IndexChgChg(%)
Nifty16,818.1-40.5-0.2
Sensex56,410.0-188.3-0.3
Mid Cap24,513.075.40.3
Small Cap28,047.1176.50.6
 
Global Indices
IndexChgChg(%)
Dow Jones29,683.711.7
Nasdaq 11,051.612.2
S&P 1001,694.111.9
Hang Seng17,250.91-2.6
Nikkei 22526,174.01-0.9
 
FII & MF Activity (Rs in Crore)
29-Sep-22BuySellNet
Cash8,328.711,928.1-3,599.4
Index Futures8,936.09,943.5-1,007.5
Stock Futures32,903.831,674.91,228.9
DII15,193.212,031.43,161.7
 
Top Gainers & Losers
GainersClose PriceChgChg(%)
ONGC126.74.13.4
Hindalco371.210.52.9
Apollo Hospital Ent.4,391.7122.82.9
HDFC Life Insurance528.013.62.6
ITC333.18.12.5
LosersClose PriceChgChg(%)
Asian Paints3,384.8-185.9-5.2
Adani Enterprises3,470.7-78.1-2.2
Tech Mahindra1,007.1-22.6-2.2
Hero MotoCorp2,536.3-55.1-2.1
Bajaj Auto3,476.7-69.2-2.0
 
Market Breadth
 AdvancesDeclinesNo Chg
BSE4,2422,91966
NSE2,1911,40926
 
Commodities & Currency (MCX Futures)
29-Sep-22ValueChgChg(%)
Gold49,994.0244.00.5
Crude6,700.015.00.2
Silver56,160.0-368.0-0.7
INR/USD80.70.81.0
 
 Commentary
Sensex on Thursday closed 188 points lower at 56,410.  Among sectors IT, Power and Utilities lost 0.6% to 1.3% each. Among stocks Titan, TechM, and Asain paints lost 1.7% to 5.2% each. Market breadth was positive with 1,806 advances against 1,633 declines. Nifty closed 41 points lower at 16,818. Today we expect the markets to open on a negative note on the back of a negative SGX nifty compared to nifty close. US markets closed on a negative note. Dow closed 1.5% lower; Nasdaq closed 2.8% lower. Today, US markets will see data release on Core PCE Price Index m/m.   Asian mar ...
More...
 
News Analysis
Hero MotoCorp to collaborate with US-based electric motorcycles and powertrains manufacturer
The company is finalizing a collaboration agreement with Zero Motorcycles, a California-based manufacturer of premium electric motorcycles and powertrains. The collaboration will focus on co-developing electric motorcycles. The company's board also a ...
Lupin receives US FDA nod for Mirabegron tablets
The company has received approval from the United States Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA), Mirabegron extended-release tablets, to market in the US. Mirabegron is a generic equivalent of Myrbetriq ext ...
Rail Vikas Nigam bags contract for construction of 4 lane highway in Andhra Pradesh
The company has received a contract for the construction of 4 lane highway from Samarlakota to Achampeta Junction, from the National Highways Authority of India (NHAI). The contract is a part of Kakinada port to NH - 16 connectivity in Andhra Pradesh ...
Ircon International commissions Hajipur-Bachhwara doubling project
The public sector enterprise has completed the commissioning of doubling work of Hajipur- Bachhwara of 72 route km including electrification. Ircon was appointed by East Central Railways for this work.
Tata Communications launches Private 5G Global Centre of Excellence in India
The company launched a private 5G global Centre of Excellence in Pune to accelerate Industry 4.0 applications and capabilities for enterprises.
Adani Ports and Special Economic Zone has incorporated a wholly-owned subsidiary for sourcing, transporting, supplying, and trading aviation-related fuels
The company said it has incorporated a wholly-owned subsidiary Adani Aviation Fuels (AAFL) to carry on the business of sourcing, transporting, supplying, and trading aviation-related fuels. APSEZ said that AAFL will commence its business operations i ...
Gulf Oil Lubricants announced an exclusive partnership
The company announced its exclusive partnership with Piaggio Vehicles and Switch Mobility for a special range of electric vehicle fluids. Under the collaboration, the Hinduja Group company will officially supply EV fluids to the two EV makers for the ...
 
Ventura Securities Limited
Corporate Office: I-Think Techno Campus, "B" Wing, 8th Floor, Pokhran Road No.2, Off. Eastern Express Highway, Thane (West) - 400 607. Maharashtra.
Phone  +91 22 67547000   Mail  Email: research@ventura1.com
Disclaimer